Sun Pharma today announced that one of its subsidiaries has received final approval from US FDA for its Abbreviated New Drug Application (ANDA) for generic version of Glumetza, Metformin Hydrochloride extended release tablets 500 mg and 1000 mg.
These Metformin Hydrochloride extended release tablets are therapeutic equivalents of Santarus Inc.’s Glumetza
For more information view website
